An open-label, randomized, 3-way crossover study to evaluate the relative bioavailability of a single oral dose of naproxen 500 mg administered as PN 400 (naproxen / esomeprazole), as the [active comparator 1], or as [active comparator 2] in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2010
At a glance
- Drugs Esomeprazole/naproxen; Naproxen
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors POZEN
- 09 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2008 New trial record.